AnalystsMatthew StantonMatthew Stanton's Stock Forecasts
AnalystsMatthew Stanton
Analyst Ranking
Bottom 33%
#3093 out of 4572 analysts
Average Return
-2.79%
Win Rate
33%1 out of 3
Risk vs Reward
Poor
Good
Matthew Stanton's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Biolife Solutions IncBLFS | +3.71% | $17.51 | $18.16 | 2024-04-03 - 2024-05-02 | Strong Buy |
Matthew Stanton Analyst Color
Get additional color on Matthew Stanton's coverage of popular stocks
Matthew Stanton's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cryoport IncCYRX | 1 | Strong Buy | $21.00 | +22.38% | Assumes | a month ago |
Standard Biotools IncLAB | 1 | Strong Buy | $3.25 | +28.46% | Initiates Coverage On | a month ago |
Biolife Solutions IncBLFS | 1 | Strong Buy | $22.00 | +21.15% | Initiates Coverage On | a month ago |
Azenta IncAZTA | 1 | Hold | $64.00 | +21.74% | Initiates Coverage On | a month ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.